NIKILA V. KUMAR M.D. NPI 1295095495

NPI Details

Nikila V. Kumar, M.D. is a rheumatology internal medicine in Phoenix, AZ with 13 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Nikila V. Kumar, M.D. NPI is 1295095495. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2012

The provider's business location address is:

4550 E BELL RD STE 170
PHOENIX, AZ
ZIP 85032-385
Phone: (480) 443-8400
Fax: (480) 443-8697

The NPI 1295095495 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg (HCPCS:J7328)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS:Q5104)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, infliximab-axxq, biosimilar, (avsola), 10 mg (HCPCS:Q5121)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Analysis for antibody to coccidioides (bacteria) (HCPCS:86635)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Vitamin d-3 level (HCPCS:82306)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Hepatitis c antibody measurement (HCPCS:86803)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Tuberculosis test, gamma interferon (HCPCS:86480)
• Total protein level, urine (HCPCS:84156)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
• Complete ultrasound scan of joint (HCPCS:76881)
• X-ray of chest, 2 views (HCPCS:71046)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Uric acid level, blood (HCPCS:84550)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Rheumatoid factor level (HCPCS:86431)
• Urinalysis, manual test (HCPCS:81002)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• X-ray of knee, 3 views (HCPCS:73562)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Phosphate level (HCPCS:84100)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• Dxa bone density measurement of forearm, finger, hand, or foot (HCPCS:77081)
• X-ray of hand, 2 views (HCPCS:73120)
• Screening test for autoimmune disorder (HCPCS:86038)
• Magnesium level (HCPCS:83735)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 5/22/2012 and was last updated on 8/18/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.